When applying the DILI severity index (taking into consideration ALT, ALP, bilirubin, INR, hospitalization, and decompensated liver disease) [12], it is highlighted that 81% of the patients (29 patients) were categorized as having a mild hepatic disease, whereas 19% of them (7 patients) were classified as having a moderate–severe or severe disease. The gene discussed is GPT; the disease is liver disorder.